adj.

猛毒な、有毒な。毒気を含む、悪意に満ちた、憎しみに燃えた。毒々しい、どぢつい、苛酷な。(医)悪性の。(菌)毒性の

Fukuda says this particular strain of swine flu could become more or less virulent over time.

関: pathogenesis、pathogenetic、pathogenic、pathogenicity、toxic、toxicity、virulence

WordNet

infectious; having the ability to cause disease
of or relating to or caused by a toxin or poison; "suffering from exposure to toxic substances"
the degree to which something is poisonous
not virulent; unable to produce disease
in a virulent manner; "an old woman advanced a few paces to shake her fist virulently in my face"

PrepTutorEJDIC

有毒な,毒性の / 憎悪に満ちた,敵意に満ちた
毒性の,有毒な / 毒による
発病させる,病原性の
毒性,有毒性

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2013/07/18 15:38:56」(JST)

wiki en

[Wiki en表示]

For the album by Only Crime, see Virulence (album).

Virulence is, by MeSH definition, the degree of pathogenicity within a group or species of parasites as indicated by case fatality rates and/or the ability of the organism to invade the tissues of the host. The pathogenicity of an organism - its ability to cause disease - is determined by its virulence factors.^[1] The noun virulence derives from the adjective virulent. Virulent can describe either disease severity or a pathogen's infectivity.^[2] The word virulent derives from the Latin word virulentus, meaning "a poisoned wound" or "full of poison."^[2]^[3]

In an ecological context, virulence can be defined as the host's parasite-induced loss of fitness. Virulence can be understood in terms of proximate causes—those specific traits of the pathogen that help make the host ill—and ultimate causes—the evolutionary pressures that lead to virulent traits occurring in a pathogen strain.^[4]

Virulent bacteria[edit]

The ability of bacteria to cause disease is described in terms of the number of infecting bacteria, the route of entry into the body, the effects of host defense mechanisms, and intrinsic characteristics of the bacteria called virulence factors. Host-mediated pathogenesis is often important because the host can respond aggressively to infection with the result that host defense mechanisms do damage to host tissues while the infection is being countered.

The virulence factors of bacteria are typically proteins or other molecules that are synthesized by enzymes. These proteins are coded for by genes in chromosomal DNA, bacteriophage DNA or plasmids. In certain bacteria, mobile genetic elements and horizontal gene transfer. Therefore, strategies to combat certain bacterial infections by targeting these specific virulence factors and mobile genetic elements have been proposed.^[5] Bacteria use quorum sensing to synchronise release of the molecules. These are all proximate causes of morbidity in the host.

Methods by which bacteria cause disease[edit]

Adhesion. Many bacteria must first bind to host cell surfaces. Many bacterial and host molecules that are involved in the adhesion of bacteria to host cells have been identified. Often, the host cell receptors for bacteria are essential proteins for other functions.
Colonization. Some virulent bacteria produce special proteins that allow them to colonize parts of the host body. Helicobacter pylori is able to survive in the acidic environment of the human stomach by producing the enzyme urease. Colonization of the stomach lining by this bacterium can lead to Gastric ulcer and cancer. The virulence of various strains of Helicobacter pylori tends to correlate with the level of production of urease.
Invasion. Some virulent bacteria produce proteins that either disrupt host cell membranes or stimulate endocytosis into host cells. These virulence factors allow the bacteria to enter host cells and facilitate entry into the body across epithelial tissue layers at the body surface.
Immune response inhibitors. Many bacteria produce virulence factors that inhibit the host's immune system defenses. For example, a common bacterial strategy is to produce proteins that bind host antibodies. The polysaccharide capsule of Streptococcus pneumoniae inhibits phagocytosis of the bacterium by host immune cells.
Toxins. Many virulence factors are proteins made by bacteria that poison host cells and cause tissue damage. For example, there are many food poisoning toxins produced by bacteria that can contaminate human foods. Some of these can remain in "spoiled" food even after cooking and cause illness when the contaminated food is consumed. Some bacterial toxins are chemically altered and inactivated by the heat of cooking.

Virulent viruses[edit]

Virus virulence factors determine whether infection occurs and how severe the resulting viral disease symptoms are. Viruses often require receptor proteins on host cells to which they specifically bind. Typically, these host cell proteins are endocytosed and the bound virus then enters the host cell. Virulent viruses such as HIV, which causes AIDS, have mechanisms for evading host defenses. HIV infects T-Helper Cells, which leads to a reduction of the adaptive immune response of the host and eventually leads to an immunocompromised state. Death results from opportunistic infections secondary to disruption of the immune system caused by the AIDS virus. Some viral virulence factors confer ability to replicate during the defensive inflammation responses of the host such as during virus-induced fever. Many viruses can exist inside a host for long periods during which little damage is done. Extremely virulent strains can eventually evolve by mutation and natural selection within the virus population inside a host. The term "neurovirulent" is used for viruses such as rabies and herpes simplex which can invade the nervous system and cause disease there.

Extensively studied model organisms of virulent viruses include virus T4 and other T-even bacteriophages which infect Escherichia coli and a number of related Bacteria.

The lytic life cycle of virulent bacteriophages is contrasted by the temperate lifecycle of Temperate bacteriophages.^[6]^[7]

Evolution[edit]

According to evolutionary medicine, optimal virulence increases with horizontal transmission (between non-relatives) and decreases with vertical transmission (from parent to child). This is because the fitness of the host is bound to the fitness in vertical transmission but is not so bound in horizontal transmission.

The pathogen population can evolve once it is in the host. There are three main hypotheses about why a pathogen evolves as it does. These three models help to explain the life history strategies of parasites, including reproduction, migration within the host, virulence, etc. The three hypotheses are the Trade-Off Hypothesis, the Short-Sighted Evolution Hypothesis, and the Coincidental Evolution Hypothesis. All of these offer ultimate explanations for virulence in pathogens.

Trade-off hypothesis[edit]

At one time, some biologists argued that pathogens would tend to evolve toward ever decreasing virulence because the death of the host (or even serious disability) is ultimately harmful to the pathogen living inside. For example, if the host dies, the pathogen population inside may die out entirely. Therefore, it was believed that less virulent pathogens that allowed the host to move around and interact with other hosts should have greater success reproducing and dispersing.

But this is not necessarily the case. Pathogen strains that kill the host can increase in frequency as long as the pathogen can transmit itself to a new host, whether before or after the host dies. The evolution of virulence in pathogens is a balance between the costs and benefits of virulence to the pathogen. For example, Mackinnon and Read (2004)^[8] and Paul et al. (2004) ^[9] studied the malaria parasite using a rodent and chicken model respectively and found that there was trade-off between transmission success and virulence as defined by host mortality.

Short-sighted evolution hypothesis[edit]

Short-sighted evolution suggests that the traits that increase reproduction rate and transmission to a new host will rise to high frequency within the pathogen population. These traits include the ability to reproduce sooner, reproduce faster, reproduce in higher numbers, live longer, survive against antibodies, or survive in parts of the body the pathogen does not normally infiltrate. These traits typically arise due to mutations, which occur more frequently in pathogen populations than in host populations, due to the pathogens' rapid generation time and immense numbers. After only a few generations, the mutations that enhance rapid reproduction or dispersal will increase in frequency. The same mutations that enhance the reproduction and dispersal of the pathogen also enhance its virulence in the host, causing much harm (disease and death). If the pathogen's virulence kills the host and interferes with its own transmission to a new host, virulence will be selected against. But as long as transmission continues despite the virulence, virulent pathogens will have the advantage. So, for example, virulence often increases within families, where transmission from one host to the next is likely, no matter how sick the host. Similarly, in crowded conditions such as refugee camps, virulence tends to increase over time since new hosts cannot escape the likelihood of infection.

Coincidental evolution hypothesis[edit]

Some forms of pathogenic virulence did not co-evolve with the host. For example, tetanus is caused by the soil bacterium Clostridium tetani. After C. tetani bacteria enter a human wound, the bacteria may grow and divide rapidly, even though the human body is not their normal habitat. While dividing, C. tetani produce a neurotoxin that is lethal to humans. But it is selection in the bacterium's normal life cycle in the soil that leads it to produce this toxin, not any evolution with a human host. The bacterium finds itself inside a human instead of in the soil by mere happenstance. We can say that the neurotoxin is not directed at the human host.

More generally, the virulence of many pathogens in humans may not be a target of selection itself, but rather an accidental by-product of selection that operates on other traits, as is the case with antagonistic pleiotropy

References[edit]

^ MeSH - Medical Subject Headings, Karolinska Institute, 13 April 2010
^ ^a ^b Compact Oxford English Dictionary virulent
^ A Latin Dictionary virulentus
^ Encyclopædia Britannica Online, 25 May 2009. "plant disease development"
^ Keen, E. C. (2012). "Paradigms of pathogenesis: Targeting the mobile genetic elements of disease". Frontiers in Cellular and Infection Microbiology 2. doi:10.3389/fcimb.2012.00161. edit
^ Madigan M, Martinko J (editors) (2006). Brock Biology of Microorganisms (11th ed.). Prentice Hall. ISBN 0-13-144329-1.
^ Encyclopædia Britannica Online, 2009. "lytic phage"
^ Mackinnon, M; A Read (2004). "Virulence in malaria: an evolutionary viewpoint". Philosophical Transactions of the Royal Society of London Series B-Biological Sciences 359 (1446). doi:10.1098/rstb.2003.1414.
^ Paul, R; T Lafond, CDM Muller-Graf, S Nithiuthai, PT Brey, JC Koella (2004). "Experimental evaluation of the relationship between lethal or non-lethal virulence and transmission success in malaria parasite infections.". BMC Evolutionary Biology 4. doi:10.1186/1471-2148-4-30.

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 肺炎桿菌感染症の微生物学および病因 microbiology and pathogenesis of klebsiella pneumoniae infection
2. エルシニア感染の微生物学および病因 microbiology and pathogenesis of yersinia infections
3. Microbiology, epidemiology, and pathogenesis of Rhodococcus equi infections
4. 人工関節感染の臨床症状および診断 clinical manifestations and diagnosis of prosthetic joint infections
5. 炭疽菌の微生物学、病因、および疫学 microbiology pathogenesis and epidemiology of anthrax

English Journal

Evaluation of substituted methyl cyclohexanone hybrids for anti-tubercular, anti-bacterial and anti-fungal activity: Facile syntheses under catalysis by ionic liquids.

Ghatole AM1, Lanjewar KR2, Gaidhane MK3, Hatzade KM4.
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.Spectrochim Acta A Mol Biomol Spectrosc.2015 Dec 5;151:515-24. doi: 10.1016/j.saa.2015.06.035. Epub 2015 Jun 17.
An library of unresolved racemic Mannich bases incorporating two stereogenic carbon centers was evaluated for antibacterial activity against clinically isolated Gram-positive bacteria i.e. Staphylococcus aureus, Gram-negative bacteria Escherichia coli and Pseudomonas aeruginosa and for antifungal ac
PMID 26162339

Prevalence of virulence genes of biofilm producing strains of Staphylococcus epidermidis isolated from clinical samples in Iran.

Solati SM1, Tajbakhsh E, Khamesipour F, Gugnani HC.
AMB Express.AMB Express.2015 Dec;5(1):134. doi: 10.1186/s13568-015-0134-3. Epub 2015 Aug 9.
Coagulase negative staphylococci are recognized as opportunistic pathogens and are widespread in the environment. It is possible to prevent and control infections due to these bacteria if their virulence factors are recognized. Eighty isolates of Staphylococcus epidermidis (S. epidermidis) including
PMID 26253391

Genetic interactions between the Golgi Ca2+/H+ exchanger Gdt1 and the plasma compartmembrane calcium channel Cch1/Mid1 in the regulation of calcium homeostasis, stress response and virulence in Candida albicans.

Wang Y1, Wang J1, Cheng J2, Xu D1, Jiang L3.
FEMS yeast research.FEMS Yeast Res.2015 Nov;15(7). pii: fov069. doi: 10.1093/femsyr/fov069. Epub 2015 Jul 23.
The Golgi-localized Saccharomyces cerevisiae ScGdt1 is a member of the cation/Ca(2+) exchanger superfamily. We show here that Candida albicans CaGdt1 is the functional homolog of ScGdt1 in calcium sensitivity, and shows genetic interactions with CaCch1 or CaMid1 in response to ER stresses. In additi
PMID 26208803

Francisella tularensis type B ΔdsbA mutant protects against type A strain and induces strong inflammatory cytokine and Th1-like antibody response in vivo.

Straskova A1, Spidlova P2, Mou S3, Worsham P3, Putzova D2, Pavkova I2, Stulik J2.
Pathogens and disease.Pathog Dis.2015 Nov;73(8). pii: ftv058. doi: 10.1093/femspd/ftv058. Epub 2015 Aug 6.
Francisella tularensis subspecies tularensis is a highly virulent intracellular bacterial pathogen, causing the disease tularemia. However, a safe and effective vaccine for routine application against F. tularensis has not yet been developed. We have recently constructed the deletion mutants for the
PMID 26253078

Japanese Journal

Buruli Ulcer and Mycolactone-Producing Mycobacteria

Nakanaga Kazue,Yotsu Rie Roselyne,Hoshino Yoshihiko,Suzuki Koichi,Makino Masahiko,Ishii Norihisa
Japanese Journal of Infectious Diseases 66(2), 83-88, 2013
… It possesses a giant virulent plasmid, composed of 174-kbp nucleotides, coding polyketide synthase to produce macrolide toxin called mycolactone. …
NAID 130003381664

A Liver Abscess Deprived a Healthy Adult of Eyesight: Endogenous Endophthalmitis Associated with a Pyogenic Liver Abscess Caused by Serotype K1 Klebsiella Pneumonia

Maruno Takahisa,Ooiwa Yoko,Takahashi Ken,Kodama Yuzo,Takakura Shunji,Ichiyama Satoshi,Chiba Tsutomu
Internal Medicine 52(8), 919-922, 2013
… Among the types of Klebsiella pneumonia, serotype K1 is known to be a highly virulent pathogen. …
NAID 130003365995

Septic Arthritis Subsequent to Urosepsis Caused by Hypermucoviscous Klebsiella pneumoniae

Suzuki Kei,Nakamura Akiko,Enokiya Tomoyuki,Iwashita Yoshiaki,Tomatsu Eri,Muraki Yuichi,Kaneko Toshihiro,Okuda Masahiro,Katayama Naoyuki,Imai Hiroshi
Internal Medicine 52(14), 1641-1645, 2013
… Although this virulent phenotype of K. …
NAID 130003365705

歯周病関連細菌Porphyromonas gingivalisのFimA線毛に関する研究

永野恵司
YAKUGAKU ZASSHI 133(9), 963-974, 2013
… Therefore, they are predicted to be high virulent types, but the molecular mechanisms remain unclear. …
NAID 130003361990